Nuvalent, Inc. - Class A Common Stock (NUVL)

Nuvalent Inc is a biopharmaceutical company focused on developing targeted therapies for patients with cancer

The company specializes in creating innovative drug candidates that aim to effectively treat specific types of tumors by addressing the underlying genetic mechanisms driving disease progression. By leveraging advanced science and technology, Nuvalent strives to improve treatment options and outcomes for patients with difficult-to-treat cancers, emphasizing precision medicine to enhance the efficacy and safety of oncology treatments.